Novel Retinoic Acid Derivative Induces Differentiation and Growth Arrest in Neuroblastoma

INTRODUCTION: Retinoic acid (RA) is a differentiating agent utilized as maintenance therapy for high-risk neuroblastoma (NB), but associated toxicities limit its use. We have previously shown that a non-toxic, novel rexinoid, 9-cis-UAB30 (UAB30), decreased NB cell proliferation and in vivo tumor gro...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Pediatr Surg
Egile Nagusiak: Marayati, Raoud, Williams, Adele P., Bownes, Laura V., Quinn, Colin H., Stewart, Jerry E., Mroczek-Musulman, Elizabeth, Atigadda, Venkatram R., Beierle, Elizabeth A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7299742/
https://ncbi.nlm.nih.gov/pubmed/32164984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpedsurg.2020.02.027
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak